Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 152.60
+1.00 (0.66%)
At close: Feb 20, 2026
Medacta Group Market Cap
Medacta Group has a market cap or net worth of 3.04 billion as of February 20, 2026. Its market cap has increased by 31.73% in one year.
Market Cap
3.04B
Enterprise Value
3.25B
Revenue
603.41M
Ranking
n/a
PE Ratio
34.33
Stock Price
152.60
Market Cap Chart
Since April 4, 2019, Medacta Group's market cap has increased from 1.92B to 3.04B, an increase of 58.35%. That is a compound annual growth rate of 6.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 3.02B | -3.07% |
| Dec 30, 2025 | 3.12B | 46.66% |
| Dec 30, 2024 | 2.13B | -15.15% |
| Dec 29, 2023 | 2.51B | 21.81% |
| Dec 30, 2022 | 2.06B | -27.53% |
| Dec 30, 2021 | 2.84B | 62.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 294.58B |
| Novartis AG | 243.06B |
| Lonza Group AG | 37.43B |
| Galderma Group AG | 37.06B |
| Galenica AG | 5.08B |
| Ypsomed Holding AG | 4.09B |
| Siegfried Holding AG | 3.94B |
| Cosmo Pharmaceuticals | 1.95B |